The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: British Journal of Cancer, 110, 2, S. 435-440
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2013
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2013
- Urheber
-
Stotz, M.
Pichler, Martin
Absenger, G.
Szkandera, J.
Arminger, F.
Schaberl-Moser, R.
Samonigg, H.
Stojakovic, T.
Gerger, A.
- DOI
-
10.1038/bjc.2013.785
- URN
-
urn:nbn:de:bvb:384-opus4-1036367
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stotz, M.
- Pichler, Martin
- Absenger, G.
- Szkandera, J.
- Arminger, F.
- Schaberl-Moser, R.
- Samonigg, H.
- Stojakovic, T.
- Gerger, A.
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2013
Ähnliche Objekte (12)
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Emerging role of non-coding RNAs in regulation of t-lymphocyte function
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Emerging role of non-coding RNAs in regulation of t-lymphocyte function
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Emerging role of non-coding RNAs in regulation of t-lymphocyte function